Hasil Pencarian - Napa Parinyanitikul

  • Menampilkan 1 - 8 hasil dari 8
Perbaiki Hasil
  1. 1
    Lactic acidosis, a potential toxicity from drug–drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report

    Lactic acidosis, a potential toxicity from drug–drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report oleh Chalita Lagampan, Nattaya Poovorawan, Napa Parinyanitikul

    Diterbitkan 2022-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  2. 2
    Genomic medicine and cancer clinical trial in Thailand

    Genomic medicine and cancer clinical trial in Thailand oleh Lucksamon Thamlikitkul, Napa Parinyanitikul, Virote Sriuranpong

    Diterbitkan 2024-01-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  3. 3
    Development and validation of a rapid psychosocial well-being screening tool in patients with metastatic breast cancer

    Development and validation of a rapid psychosocial well-being screening tool in patients with metastatic breast cancer oleh Bhumipat Thanasansomboon, Songphan Choemprayong, Napa Parinyanitikul, Uthai Tanlamai, Manika Wisessathorn, Yupin Patarapongsant

    Diterbitkan 2022-07-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  4. 4
    Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene

    Tumor mutational profile of triple negative breast cancer patients in Thailand revealed distinctive genetic alteration in chromatin remodeling gene oleh Suvimol Niyomnaitham, Napa Parinyanitikul, Ekkapong Roothumnong, Worapoj Jinda, Norasate Samarnthai, Taywin Atikankul, Bhoom Suktitipat, Wanna Thongnoppakhun, Chanin Limwongse, Manop Pithukpakorn

    Diterbitkan 2019-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  5. 5
    Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-world data from Thailand

    Comparative effectiveness analysis of survival with first-line palbociclib or ribociclib plus AI in HR + /HER2- advanced breast cancer (CEPRA study): preliminary analysis of real-w... oleh Thanate Dajsakdipon, Thiti Susiriwatananont, Concord Wongkraisri, Suthinee Ithimakin, Napa Parinyanitikul, Archara Supavavej, Arunee Dechaphunkul, Patrapim Sunpaweravong, Sunee Neesanun, Charuwan Akewanlop, Thitiya Dejthevaporn, TSCO Breast Oncology Group

    Diterbitkan 2024-08-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  6. 6
    614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study

    614 Safety and efficacy of YBL-006, a novel anti-PD-1 antibody, in advanced solid tumors including G3 NET/NEC: results from a phase 1/2A study oleh Bhumsuk Keam, Chan-Young Ock, Do-Youn Oh, Seung-Tae Kim, Keun-Wook Lee, Sun Young Rha, Changhoon Yoo, John Park, Min Hwan Kim, Sehyun Kim, Dhanusha Sabanathan, Joon Oh Park, Napa Parinyanitikul, Kyu Pyo Kim, Jaebong Yoon, Hyelim Lim, Sangheon Lee, Wooick Jang

    Diterbitkan 2023-11-01
    Artikel
    Simpan ke Daftar
    Disimpan di:
  7. 7
    Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel

    Optimizing outcomes for patients with metastatic prostate cancer: insights from South East Asia Expert Panel oleh Fabio Augusto Barros Schutz, Ekaphop Sirachainan, Shanggar Kuppusamy, Nguyen Thi Thai Hoa, Thitiya Dejthevaporn, Badrulhisham Bahadzor, Vu Quang Toan, Phichai Chansriwong, Adlinda Alip, Nguyen Thi Minh Hue, Napa Parinyanitikul, Ai Lian Tan, Vu Dinh Khanh Hoang, Piyawan Tienchaiananda, Sai Naga Deepak Chinchapattanam, Amit Garg

    Diterbitkan 2021-02-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:
  8. 8
    Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study

    Immunogenicity of ChAdOx1-nCoV-19 vaccine in solid malignancy patients by treatment regimen versus healthy controls: A prospective, multicenter observational study oleh Nattaya Teeyapun, Sutima Luangdilok, Nussara Pakvisal, Panot Sainamthip, Siyamol Mingmalairak, Nattaya Poovorawan, Piyada Sitthideatphaiboon, Napa Parinyanitikul, Virote Sriuranpong, Teerayuth Namkanisorn, Pratchaya Inthasuwan, Pattama Angspatt, Ploytuangporn Wongchanapat, Akradach Bamrungnam, Nutchanok Leeleakpai, Sutheera Uttha, Supaporn Jaichum, Peerawich Kongkaew, Chayanin Suksanong, Rattiya Veranitinun, Ampai Prasomphol, Chada Sartsuk, Cheeraporn Patcharajutanon, Supreeya Preaprang, Hathairat Choengsamor, Rungthong Phongwan, Charoenpit Preeyasaksa, Ekkamol Phaibulvatanapong, Nungruthai Suntronwong, Ritthideach Yorsaeng, Preeyaporn Vichaiwattana, Nasamon Wanlapakorn, Stephen J. Kerr, Yong Poovorawan, Passakorn Wanchaijiraboon, Suebpong Tanasanvimon

    Diterbitkan 2022-10-01
    Dapatkan teks lengkap
    Artikel
    Simpan ke Daftar
    Disimpan di:

Alat Pencarian: